Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data

Por Wang, Huixia, Huang, Shuguang, Shou, Jianyong, Su, Eric W, Onyia, Jude E, Liao, Birong, Li, Shuyu
Publicado em 2006

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

Por Nishizuka, Satoshi, Charboneau, Lu, Young, Lynn, Major, Sylvia, Reinhold, William C., Waltham, Mark, Kouros-Mehr, Hosein, Bussey, Kimberly J., Lee, Jae K., Espina, Virginia, Munson, Peter J., Petricoin, Emanuel, Liotta, Lance A., Weinstein, John N.
Publicado em 2003

NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses

Por Reinhold, William C., Varma, Sudhir, Sousa, Fabricio, Sunshine, Margot, Abaan, Ogan D., Davis, Sean R., Reinhold, Spencer W., Kohn, Kurt W., Morris, Joel, Meltzer, Paul S., Doroshow, James H., Pommier, Yves
Publicado em 2014

Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data

Por Wang, Yu-Ping, Li, Kuo-Bin
Publicado em 2009

Novel fluoroindenoisoquinoline non-camptothecin topoisomerase I inhibitors

Por Marzi, Laetitia, Agama, Keli, Murai, Junko, Difilippantonio, Simone, James, Amy, Peer, Cody J., Figg, William D., Beck, Daniel, Elsayed, Mohamed. S. A., Cushman, Mark, Pommier, Yves
Publicado no Mol Cancer Ther (2018)

Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998–2011

Por Kurian, Allison W., Lichtensztajn, Daphne Y., Keegan, Theresa H. M., Nelson, David O., Clarke, Christina A., Gomez, Scarlett L.
Publicado no JAMA (2014)

Topoisomerase-I PS506 as a Dual Function Cancer Biomarker

Por Zhao, Ming, Gjerset, Ruth A.
Publicado no PLoS One (2015)

Delphinidin Reduces Cell Proliferation and Induces Apoptosis of Non-Small-Cell Lung Cancer Cells by Targeting EGFR/VEGFR2 Signaling Pathways

Por Pal, Harish Chandra, Sharma, Samriti, Strickland, Leah Ray, Agarwal, Jyoti, Athar, Mohammad, Elmets, Craig A., Afaq, Farrukh
Publicado em 2013

[-2]proPSA for Prostate Cancer Detection: an NCI Early Detection Research Network Validation Study

Por Sokoll, Lori J., Wang, Yinghui, Feng, Ziding, Kagan, Jacob, Partin, Alan W., Sanda, Martin G., Thompson, Ian M., Chan, Daniel W.
Publicado em 2008

T25

Por E. Lesovaya, L. Tilova, O. Zadorozhnaya, A. Savinkova, K. Kirsanov, A. Ogloblina, G. Belitsky, G. Baida, I. Budunova, M. Yakubovskaya
Publicado em 2015-11-01

Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N′bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLC

Por DeBord, Michael A., Southerland, Marie R., Wagers, Patrick O., Tiemann, Kristin M., Robishaw, Nikki K., Whiddon, Kyle T., Konopka, Michael C., Tessier, Claire A., Shriver, Leah P., Paruchuri, Sailaja, Hunstad, David A., Panzner, Matthew J., Youngs, Wiley J.
Publicado no Bioorg Med Chem Lett (2017)

Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study

Por Ramirez, Amelie G, Pérez-Stable, Eliseo J, Talavera, Gregory A, Penedo, Frank J, Carrillo, J Emilio, Fernandez, Maria E, Muñoz, Edgar, Long Parma, Dorothy, Holden, Alan EC, San Miguel de Majors, Sandra, Nápoles, Anna, Castañeda, Sheila F, Gallion, Kipling J
Publicado em 2013

DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53

Por Alam, S K, Yadav, V K, Bajaj, S, Datta, A, Dutta, S K, Bhattacharyya, M, Bhattacharya, S, Debnath, S, Roy, S, Boardman, L A, Smyrk, T C, Molina, J R, Chakrabarti, S, Chowdhury, S, Mukhopadhyay, D, Roychoudhury, S
Publicado no Cell Death Differ (2016)

High Dose Rate Brachytherapy in the Treatment of cervical cancer: preliminary experience with cobalt 60 Radionuclide source—A Prospective Study

Por Ntekim, Atara, Adenipekun, Adeniyi, Akinlade, Bidemi, Campbell, Oladapo
Publicado em 2010

Laboratory Evolution of GH11 Endoxylanase Through DNA Shuffling: Effects of Distal Residue Substitution on Catalytic Activity and Active Site Architecture

Por Ming-Qi Liu, Jia-Yi Li, Ashfaq Ur Rehman, Xin Xu, Zhu-Jun Gu, Ruo-Chen Wu
Publicado em 2019-11-01

Anti-cancer effect of low dose of celecoxib may be associated with lnc-SCD-1:13 and lnc-PTMS-1:3 but not COX-2 in NCI-N87 cells

Por Song, Bin, Shu, Zhen-Bo, Du, Juan, Ren, Ji-Chen, Feng, Ye
Publicado no Oncol Lett (2017)

Microwave-Assisted Synthesis of Novel Pyrazolo[3,4-g][1,8]naphthyridin-5-amine with Potential Antifungal and Antitumor Activity

Por Acosta, Paola, Butassi, Estefanía, Insuasty, Braulio, Ortiz, Alejandro, Abonia, Rodrigo, Zacchino, Susana A., Quiroga, Jairo
Publicado no Molecules (2015)

Nanoparticle analysis sheds budding insights into genetic drivers of extracellular vesicle biogenesis

Por Hurwitz, Stephanie N., Conlon, Meghan M., Rider, Mark A., Brownstein, Naomi C., Meckes, David G.
Publicado no J Extracell Vesicles (2016)

Dimers of melampomagnolide B exhibit potent anticancer activity against hematological and solid tumor cells

Por Janganati, Venumadhav, Ponder, Jessica, Jordan, Craig T., Borrelli, Michael J., Penthala, Narsimha Reddy, Crooks, Peter A.
Publicado no J Med Chem (2015)

The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

Por Faur, N, Araud, L, Laroche-Clary, A, Kanno, J, Toutain, J, Yamori, T, Robert, J, Le Morvan, V
Publicado em 2009